Insights

fda

7 min read • February 5, 2025

Cannabis Takes On Superbugs: Could This New Drug ‘Change Infection Treatment Forever’?

4 min read • November 28, 2024

The Mold-Killing Machine For Weed That Would Survive The New Shark Tank Season

2 min read • November 20, 2024

FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

3 min read • October 24, 2024

JD Vance Pushes Debunked Claim Of Fentanyl-Laced Marijuana Despite New Harvard-Led Study Findings

5 min read • October 16, 2024

Why Pennsylvania’s GOP Districts Are Embracing Weed: The Cannabis Revolution You Didn’t See Coming

1 min read • September 26, 2024

“National Agriculture Regulators Group Grapples With Intoxicating Hemp For The First Time; FDA’s Norm Birenbaum Says Existing FDA Regulatory Frameworks ‘Do Not Apply To Large Segments Of The Market, Like Inhalable Products, Where We Have Tremendous Concerns'” – Cannabis Wire

3 min read • September 24, 2024

DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

5 min read • August 28, 2024

Cannabis And Psychedelics Industries: Summer’s Over, Where Are We?

2 min read • August 22, 2024

Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company

2 min read • August 2, 2024

Cannabis Pharmaceuticals: Company With Ties To Groundbreaking Medical Developments Pursues Cannabinoid-Based Medicines

3 min read • July 24, 2024

Harris Vs. Trump: Will Cannabis Rescheduling Survive Biden’s Exit? Analyst On Potential GOP Victory

4 min read • May 22, 2024

Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock’s Market Cap By 170%

Latest Headlines

View All

3 min read • September 4, 2026

Fatal Oklahoma Cannabis Blast Intensifies Scrutiny Of State Marijuana Regulation

7 min read • September 4, 2026

Cannabis M&A Enters Its Distressed-Asset Era: What Cresco’s $50 Million Pennsylvania Deal Must Deliver

2 min read • September 3, 2026

Aurora CEO On Curaleaf Takeover: ‘It’s Clear Why They Want It,’ But Offer Isn’t Adequate

6 min read • September 3, 2026

Organigram Says Germany’s Cannabis Market Could Double — Here’s How It Plans to Capitalize

5 min read • September 2, 2026

Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights

10 min read • September 2, 2026

Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround

3 min read • September 2, 2026

Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows

2 min read • September 2, 2026

UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share

7 min read • September 2, 2026

Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation

3 min read • September 1, 2026

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

8 min read • September 1, 2026

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

2 min read • September 1, 2026

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

Browse By Channels

Broad U.S. Equity ETFs

first quarter earnings

illegal cannabis farms

intoxicating hemp-derived products

Macro Economic Events

Market-Moving Exclusives

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

View Insights

Secure Access

fda

Cannabis Takes On Superbugs: Could This New Drug ‘Change Infection Treatment Forever’?

The Mold-Killing Machine For Weed That Would Survive The New Shark Tank Season

FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

JD Vance Pushes Debunked Claim Of Fentanyl-Laced Marijuana Despite New Harvard-Led Study Findings

Why Pennsylvania’s GOP Districts Are Embracing Weed: The Cannabis Revolution You Didn’t See Coming

“National Agriculture Regulators Group Grapples With Intoxicating Hemp For The First Time; FDA’s Norm Birenbaum Says Existing FDA Regulatory Frameworks ‘Do Not Apply To Large Segments Of The Market, Like Inhalable Products, Where We Have Tremendous Concerns'” – Cannabis Wire

DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

Cannabis And Psychedelics Industries: Summer’s Over, Where Are We?

Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company

Cannabis Pharmaceuticals: Company With Ties To Groundbreaking Medical Developments Pursues Cannabinoid-Based Medicines

Harris Vs. Trump: Will Cannabis Rescheduling Survive Biden’s Exit? Analyst On Potential GOP Victory

Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock’s Market Cap By 170%

Fatal Oklahoma Cannabis Blast Intensifies Scrutiny Of State Marijuana Regulation

Cannabis M&A Enters Its Distressed-Asset Era: What Cresco’s $50 Million Pennsylvania Deal Must Deliver

Aurora CEO On Curaleaf Takeover: ‘It’s Clear Why They Want It,’ But Offer Isn’t Adequate

Organigram Says Germany’s Cannabis Market Could Double — Here’s How It Plans to Capitalize

Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights

Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround

Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows

UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share

Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

Browse By Channels

Join the Cannabis Revolution

Insights

Insights Tips